Surgical Implant Co. Settles Securities Suit For $10.5M
A surgical implant company has agreed to pay $10.5 million to end a class action accusing it of manipulating revenue reports by regularly shipping products to customers ahead of schedule to...To view the full article, register now.
Already a subscriber? Click here to view full article